Sinovac has reported that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during the three-day observation of safety, the preliminary tests on the A/H1N1 influenza vaccine have indicated that the vaccine is safe and reliable in humans.
Reportedly, a total of 1,614 volunteers, including 101 elders, 706 adults, 404 juvenile and 403 children, had received the first shot of the vaccine through 25 July 2009.
The clinical trial is organized by China’s Center for Disease Control (CDC), and undertaken by Beijing CDC.
In June 2009, the company announced that the Ministry of Health had made an initial order of 4 million doses of Panflu, which is expected to be delivered by the end of September.
Sinovac’s seasonal influenza vaccine has been released by China SFDA and officially launched to the market at the end of July 2009.